Founded in Israel in 2013, Smartzyme Biopharma specializes in protein, enzyme, and mRNA-based therapeutics. Smartzyme’s lead programs include a novel glucose-sensing enzyme to be incorporated into a continuous glucose sensor and a recombinant protein to treat severe acute bleeding.
Member count: 11-50
Total raised: $4M
Founded date: 2013
Investors 1
| Date | Name | Website |
| - | OrbiMed | orbimed.co... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 27.10.2015 | - | $4M | - | finsmes.co... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 15.03.2018 | Term Sheet... | ‘FRAUD IS NOT A TRADE SECRET’ ... | - | - | fortune.co... |
| 27.10.2015 | SmartZyme ... | SmartZyme, a Ness Ziona, Israe... | Israel | - | finsmes.co... |
| 27.10.2015 | Daily fund... | Taris Biomedical raised $32M; ... | - | Mitos Suso... | vator.tv/n... |